M. Peacock

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration.

U. Schopfer, S. Bevan, R. Portmann, 2007, Journal of medicinal chemistry.

Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.

I. Hardcastle, R. Griffin, B. Golding, 2010, Bioorganic & medicinal chemistry letters.

Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK).

I. Hardcastle, R. Griffin, B. Golding, 2010, Organic & biomolecular chemistry.

Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat

A. Dyson, J. Courade, A. Groarke, 2005, Pain.

Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)

S. Bevan, J. Winter, M. Clarke, 2001, British journal of pharmacology.

Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.

M. Lamers, R. Cachope, G. Mcallister, 2021, Journal of medicinal chemistry.